Southeast & Midwestern Banks

January 30, 2015

Buy ($175)

Topics covered: Regulatory Outlook Gains Clarity, Prolonged Interest Rate Environment Challenges, Investing in Regional Banks, Interest Rates and Loan-Growth Strategies, Increased Short-Term Interest Rates, Consolidation in Regional Banking, Challenging Revenue Environment, C&I Lending

Companies covered: Southwest Georgia Financial Corporation (AMEX:SGB), U.S. Bancorp (NYSE:USB), Susquehanna Bancshares, Inc. (NASDAQ:SUSQ), PNC Financial Services Group, Inc. (The) (NYSE:PNC), FirstMerit Corporation (NASDAQ:FMER), Fifth Third Bancorp (NASDAQ:FITB), Citigroup Inc. (NYSE:C), The Bank of Kentucky Financial Corp. (NASDAQ:BKYF), BB&T Corporation (NYSE:BBT), Wells Fargo & Company (NYSE:WFC), Westpac Banking Corporation (OTCMKTS:WEBNF), Visa Inc. (NYSE:V), Mastercard Incorporated (NYSE:MA), J P Morgan Chase & Co (NYSE:JPM), Discover Financial Services (NYSE:DFS), Bank of Hawaii Corporation (NYSE:BOH), Bank of America Corporation (NYSE:BAC), American Express Company (NYSE:AXP), Zions Bancorporation (NASDAQ:ZION), Webster Financial Corporation (NYSE:WBS), Signature Bank (NASDAQ:SBNY), People's United Financial, Inc. (NASDAQ:PBCT), M&T Bank Corporation (NYSE:MTB), KeyCorp (NYSE:KEY), Huntington Bancshares Incorporated (NASDAQ:HBAN), Fulton Financial Corporation (NASDAQ:FULT), First Niagara Financial Group Inc. (NASDAQ:FNFG), Comerica Incorporated (NYSE:CMA)

Investing Strategies

January 30, 2015

Buy ($175)

Topics covered: Using Volatility to Generate Income, Steady Returns from Domestic Stocks, Quality and Valuation, Outperforming Over the Long Term, Investing in Emerging Markets, Focusing on Growth, Behavioral Model Investing, Active Management in ETFs, A Quantitative Value Investment Philosophy

Companies covered: Snap-On Incorporated (NYSE:SNA), Biogen Inc. (NASDAQ:BIIB), Apple Inc. (NASDAQ:AAPL), HDFC Bank Limited (NYSE:HDB), AT&T Inc. (NYSE:T), Southern Company (The) (NYSE:SO), Procter & Gamble Company (The) (NYSE:PG), Kimberly-Clark Corporation (NYSE:KMB), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), Duke Energy Corporation (NYSE:DUK), Chevron Corporation (NYSE:CVX), Macy's Inc (NYSE:M), International Business Machines Corporation (NYSE:IBM), Gap, Inc. (The) (NYSE:GPS), Gamestop Corporation (NYSE:GME), Coach, Inc. (NYSE:COH), Best Buy Co., Inc. (NYSE:BBY)

Investing Strategies

January 16, 2015

Buy ($175)

Topics covered: Value Investment, Sector Neutrality, Midcap Growth Investing, Long-Term Investing, Investment Risk Management Strategies, High-Quality Companies, Bottom-Up Stock Selection, Balanced Investment Approach

Companies covered: Apple Inc. (NASDAQ:AAPL), Oracle Corporation (NYSE:ORCL), Valeant Pharmaceuticals International, Inc. (NYSE:VRX), Visa Inc. (NYSE:V), Mastercard Incorporated (NYSE:MA), Alphabet Inc (NASDAQ:GOOG), Allergan, Inc. (NYSE:AGN), TJX Companies, Inc. (The) (NYSE:TJX), Nike, Inc. (NYSE:NKE), L Brands, Inc. (NYSE:LB), Home Depot, Inc. (The) (NYSE:HD), Walt Disney Company (The) (NYSE:DIS), Blackhawk Network Holdings, Inc. (NASDAQ:HAWK), Western Union Company (The) (NYSE:WU), Safeway Inc. (NYSE:SWY), NVIDIA Corporation (NASDAQ:NVDA), Moneygram International, Inc. (NASDAQ:MGI), IPC Healthcare, Inc. (NASDAQ:IPCM), Greenlight Reinsurance, Ltd. (NASDAQ:GLRE), Family Dollar Stores, Inc. (NYSE:FDO), Fastenal Company (NASDAQ:FAST), Dollar Tree, Inc. (NASDAQ:DLTR), Amphenol Corporation (NYSE:APH), Medtronic, Inc. (NYSE:MDT), DexCom, Inc. (NASDAQ:DXCM), Covidien Ltd. (NYSE:COV), Cisco Systems, Inc. (NASDAQ:CSCO), Microsoft Corporation (NASDAQ:MSFT), Las Vegas Sands Corp. (NYSE:LVS), Lorillard, Inc (NYSE:LO), Kroger Company (The) (NYSE:KR), Hanesbrands Inc. (NYSE:HBI), Dow Inc. (NYSE:DOW), BP p.l.c. (NYSE:BP)

Biotechnology and Pharmaceuticals

January 16, 2015

Buy ($175)

Topics covered: Orphan Drugs, High-Quality Biotech Stocks, FDA Approval Process, Emerging Pharmaceuticals, Biotechnology Fundamentals, Biotechnology and Pharmaceuticals, Biotechnology and Pharmaceutical Investing, Biotechnology and Pharmaceutical Companies Valuation

Companies covered: The Medicines Company (NASDAQ:MDCO), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Biogen Inc. (NASDAQ:BIIB), Amgen Inc. (NASDAQ:AMGN), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Sanofi (NYSE:SNY), Pharmacyclics, Inc. (NASDAQ:PCYC), Merck & Company, Inc. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), InterMune Inc., Gilead Sciences, Inc. (NASDAQ:GILD), Express Scripts Holding Company (NASDAQ:ESRX), Cubist Pharmaceuticals Inc., Baxter International Inc. (NYSE:BAX), Celgene Corporation (NASDAQ:CELG), ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Pfizer, Inc. (NYSE:PFE), Dynavax Technologies Corporation (NASDAQ:DVAX), Provectus Biopharmaceuticals, Inc. (AMEX:PVCT), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), XOMA Corporation (NASDAQ:XOMA), United Therapeutics Corporation (NASDAQ:UTHR), La Jolla Pharmaceutical Company (NASDAQ:LJPC), Cardiome Pharma Corporation (NASDAQ:CRME)

Latest News